TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -84.2% | 167 | -86.3% | 0.00% | – |
| Q2 2023 | $19 | +533.3% | 1,217 | +628.7% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 167 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 167 | -89.7% | 0.00% | – |
| Q3 2022 | $21,000 | +950.0% | 1,628 | +874.9% | 0.00% | – |
| Q2 2022 | $2,000 | -95.9% | 167 | -95.1% | 0.00% | – |
| Q1 2022 | $49,000 | -9.3% | 3,390 | -14.6% | 0.00% | – |
| Q4 2021 | $54,000 | -11.5% | 3,971 | +6.1% | 0.00% | – |
| Q3 2021 | $61,000 | -7.6% | 3,744 | -5.0% | 0.00% | – |
| Q2 2021 | $66,000 | +6.5% | 3,940 | +16.2% | 0.00% | – |
| Q1 2021 | $62,000 | +785.7% | 3,390 | +811.3% | 0.00% | – |
| Q3 2020 | $7,000 | +600.0% | 372 | +389.5% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 76 | +68.9% | 0.00% | – |
| Q2 2019 | $1,000 | -87.5% | 45 | -88.7% | 0.00% | – |
| Q1 2019 | $8,000 | – | 397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |